Keywords: CIR; cumulative incidence of recurrence; FoxP3; forkhead box P3; H&E; hematoxylin and eosin; HPF; high-power field; IASLC/ATS/ERS; International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society; IL-7R;